Invasive Ventilation

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 22713 Experts worldwide ranked by ideXlab platform

Stefano Nava - One of the best experts on this subject based on the ideXlab platform.

  • Non-Invasive Ventilation and weaning :
    2014
    Co-Authors: Mark Elliott, Stefano Nava, Bernd Schönhofer
    Abstract:

    Non-Invasive Ventilation and weaning : , Non-Invasive Ventilation and weaning : , کتابخانه دیجیتال جندی شاپور اهواز

  • The use of non-Invasive Ventilation during acute respiratory failure due to pneumonia
    European journal of internal medicine, 2012
    Co-Authors: Miquel Ferrer, Roberto Cosentini, Stefano Nava
    Abstract:

    The use of non-Invasive Ventilation in patients with community-acquired pneumonia is controversial since this is associated with high rates of treatment failure, compared with other causes of severe acute respiratory failure. The populations of patients with community-acquired pneumonia who have demonstrated better response to non-Invasive Ventilation are those with previous cardiac or respiratory disease, particularly chronic obstructive pulmonary disease. By contrast, the use of non-Invasive Ventilation in patients with community-acquired pneumonia without these pre-existing diseases should be very cautious and under strict monitoring conditions, since there are increasing evidences that the unnecessary delay in intubation of those patients who fail treatment with non-Invasive Ventilation is associated with lower survival. Pulmonary complications of immunosuppressed patients are associated with high rates of intubation and mortality. The use of non-Invasive Ventilation in these patients may decrease the need for intubation and improve the poor outcome associated with these complications. Continuous positive airway pressure has been used to treat acute respiratory failure in several conditions characterised by alveolar collapse. While this is extremely useful in patients with acute cardiogenic pulmonary oedema, the efficacy in pneumonia seems limited to immunosuppressed patients with pulmonary complications. Conversely, there are no sufficient evidences on the efficacy of continuous positive airway pressure in immunocompetent patients with pneumonia and severe acute respiratory failure.

  • Non-Invasive Ventilation.
    Minerva anestesiologica, 2008
    Co-Authors: Stefano Nava, Paolo Navalesi, Annalisa Carlucci
    Abstract:

    Non-Invasive Ventilation (NIV) is an effective technique that can avert side effects and complications associated with endotracheal intubation. NIV is primarily used to avert the need for endotracheal intubation in patients with early stage acute respiratory failure (ARF), and to prevent postextubation respiratory failure in patients considered to be at risk. It can also be used as an alternative to Invasive Ventilation at a more advanced stage of ARF or to facilitate the process of weaning from mechanical Ventilation. The success of NIV relies on several factors including the type and severity of ARF, the underlying disease, the timing, the location of treatment, and the experience of the team. In this review article, we analyze, compare, and discuss the results of studies in which NIV was applied in different pathologies and with different timing during the evolution of ARF.

  • non Invasive Ventilation in chronic obstructive pulmonary disease patients helmet versus facial mask
    Intensive Care Medicine, 2007
    Co-Authors: Paolo Navalesi, Annalisa Carlucci, Giorgio Conti, Roberta Costa, Piero Ceriana, George Prinianakis, Massimo Antonelli, Stefano Nava
    Abstract:

    Rationale The helmet is a new interface with the potential of increasing the success rate of non-Invasive Ventilation by improving tolerance.

  • Time of non-Invasive Ventilation.
    Intensive care medicine, 2006
    Co-Authors: Stefano Nava, Paolo Navalesi, Giorgio Conti
    Abstract:

    Non-Invasive Ventilation (NIV) is a safe, versatile and effective technique that can avert side effects and complications associated with endotracheal intubation. The success of NIV relies on several factors, including the type and severity of acute respiratory failure, the underlying disease, the location of treatment, and the experience of the team. The time factor is also important. NIV is primarily used to avert the need for endotracheal intubation in patients with early-stage acute respiratory failure and post-extubation respiratory failure. It can also be used as an alternative to Invasive Ventilation at a more advanced stage of acute respiratory failure or to facilitate the process of weaning from mechanical Ventilation. NIV has been used to prevent development of acute respiratory failure or post-extubation respiratory failure. The number of days of NIV and hours of daily use differ, depending on the severity and course of the acute respiratory failure and the timing of application. In this review article, we analyse, compare and discuss the results of studies in which NIV was applied at various times during the evolution of acute respiratory failure.

Vincenzo La Bella - One of the best experts on this subject based on the ideXlab platform.

  • Predictors of non-Invasive Ventilation tolerance in amyotrophic lateral sclerosis.
    Journal of the neurological sciences, 2011
    Co-Authors: Paolo Volanti, Fabio Cibella, Maria Sarvà, Domenico De Cicco, Antonio Spanevello, Gabriele Mora, Vincenzo La Bella
    Abstract:

    The most frequent cause of death in patients with Amyotrophic Lateral Sclerosis (ALS) is respiratory failure. Recently, it has been shown that non-Invasive Ventilation improves survival and quality of life in ALS patients with respiratory failure, but little is known about predictors of non-Invasive Ventilation adaptation and tolerance. In this study we evaluated the effect of a comprehensive information about non-Invasive Ventilation use and a prolonged and intensive monitoring on tolerance to this palliative care. We prospectively monitored all consecutive ALS patients with chronic respiratory failure and indication to non-Invasive Ventilation between January 2005 and December 2007. Non-Invasive Ventilation adaptation was always performed in a hospital setting. Forty-four patients were considered eligible: six declined the non-Invasive Ventilation proposal and one was excluded due to severe fronto-temporal dementia. Non-Invasive Ventilation was offered to thirty-seven inpatients in our ALS Centre, thirty-two of whom presented with severe (n=9) or mild-moderate (n=23) bulbar impairment at non-Invasive Ventilation initiation. The mean time interval for adaptation to Ventilation was 5±2 days, but patients remained in hospital for an average extended period of one week. Thirty-five of the 37 patients who started non-Invasive Ventilation, including those with severe bulbar impairment, remained tolerant at twelve months follow-up. Our study shows that an intensive educational training and adaptation on non-Invasive Ventilation, when performed in a hospital multidisciplinary setting, increases compliance and tolerance over time, even in those patients with severe bulbar impairment. However, the design of our study, mainly based on a continuous monitoring and educational training of the patients, might not make it fully applicable to an outpatients setting. Copyright © 2010 Elsevier B.V. All rights reserved.

  • Predictors of non-Invasive Ventilation tolerance in amyotrophic lateral sclerosis.
    Journal of the Neurological Sciences, 2011
    Co-Authors: Paolo Volanti, Fabio Cibella, Maria Sarvà, Domenico De Cicco, Antonio Spanevello, Gabriele Mora, Vincenzo La Bella
    Abstract:

    Abstract Background The most frequent cause of death in patients with Amyotrophic Lateral Sclerosis (ALS) is respiratory failure. Recently, it has been shown that non-Invasive Ventilation improves survival and quality of life in ALS patients with respiratory failure, but little is known about predictors of non-Invasive Ventilation adaptation and tolerance. In this study we evaluated the effect of a comprehensive information about non-Invasive Ventilation use and a prolonged and intensive monitoring on tolerance to this palliative care. Methods We prospectively monitored all consecutive ALS patients with chronic respiratory failure and indication to non-Invasive Ventilation between January 2005 and December 2007. Non-Invasive Ventilation adaptation was always performed in a hospital setting. Results Forty-four patients were considered eligible: six declined the non-Invasive Ventilation proposal and one was excluded due to severe fronto-temporal dementia. Non-Invasive Ventilation was offered to thirty-seven inpatients in our ALS Centre, thirty-two of whom presented with severe (n = 9) or mild-moderate (n = 23) bulbar impairment at non-Invasive Ventilation initiation. The mean time interval for adaptation to Ventilation was 5 ± 2 days, but patients remained in hospital for an average extended period of one week. Thirty-five of the 37 patients who started non-Invasive Ventilation, including those with severe bulbar impairment, remained tolerant at twelve months follow-up. Conclusions Our study shows that an intensive educational training and adaptation on non-Invasive Ventilation, when performed in a hospital multidisciplinary setting, increases compliance and tolerance over time, even in those patients with severe bulbar impairment. However, the design of our study, mainly based on a continuous monitoring and educational training of the patients, might not make it fully applicable to an outpatients setting.

D Floret - One of the best experts on this subject based on the ideXlab platform.

Giorgio Conti - One of the best experts on this subject based on the ideXlab platform.

Paolo Navalesi - One of the best experts on this subject based on the ideXlab platform.

  • Non-Invasive Ventilation.
    Minerva anestesiologica, 2008
    Co-Authors: Stefano Nava, Paolo Navalesi, Annalisa Carlucci
    Abstract:

    Non-Invasive Ventilation (NIV) is an effective technique that can avert side effects and complications associated with endotracheal intubation. NIV is primarily used to avert the need for endotracheal intubation in patients with early stage acute respiratory failure (ARF), and to prevent postextubation respiratory failure in patients considered to be at risk. It can also be used as an alternative to Invasive Ventilation at a more advanced stage of ARF or to facilitate the process of weaning from mechanical Ventilation. The success of NIV relies on several factors including the type and severity of ARF, the underlying disease, the timing, the location of treatment, and the experience of the team. In this review article, we analyze, compare, and discuss the results of studies in which NIV was applied in different pathologies and with different timing during the evolution of ARF.

  • non Invasive Ventilation in chronic obstructive pulmonary disease patients helmet versus facial mask
    Intensive Care Medicine, 2007
    Co-Authors: Paolo Navalesi, Annalisa Carlucci, Giorgio Conti, Roberta Costa, Piero Ceriana, George Prinianakis, Massimo Antonelli, Stefano Nava
    Abstract:

    Rationale The helmet is a new interface with the potential of increasing the success rate of non-Invasive Ventilation by improving tolerance.

  • Time of non-Invasive Ventilation.
    Intensive care medicine, 2006
    Co-Authors: Stefano Nava, Paolo Navalesi, Giorgio Conti
    Abstract:

    Non-Invasive Ventilation (NIV) is a safe, versatile and effective technique that can avert side effects and complications associated with endotracheal intubation. The success of NIV relies on several factors, including the type and severity of acute respiratory failure, the underlying disease, the location of treatment, and the experience of the team. The time factor is also important. NIV is primarily used to avert the need for endotracheal intubation in patients with early-stage acute respiratory failure and post-extubation respiratory failure. It can also be used as an alternative to Invasive Ventilation at a more advanced stage of acute respiratory failure or to facilitate the process of weaning from mechanical Ventilation. NIV has been used to prevent development of acute respiratory failure or post-extubation respiratory failure. The number of days of NIV and hours of daily use differ, depending on the severity and course of the acute respiratory failure and the timing of application. In this review article, we analyse, compare and discuss the results of studies in which NIV was applied at various times during the evolution of acute respiratory failure.